What's breaking now, across thousands of outlets.
[SINGAPORE] The following companies saw new developments that may affect trading of their securities on Tuesday (Nov 10):
We haven't written up this one. The Business Times - Companies & Markets has the full story — the link below goes straight to it.
Its ENHANCE heart and DENOVO lung programs target thousands of procedures that currently use no machine preservation at all.
Sales slid 22% as management overhauls strategy and shifts its fiscal calendar.
Fuel squeezed profits even as seafood growth and the Searay deal lifted sales.
Phase 3 hepatitis C data met its endpoints and funding now extends into mid-2028.
